Laparoscopic vs. open anatomical hepatectomy for intrahepatic cholangiocarcinoma: A retrospective cohort study

Wang, Jianlei; Ma, Delin; Du, Gang; An, Baokun; Xia, Tong; Zhou, Tao; Sun, Qian; Liu, Fengyue; Wang, Yadong; Sui, Deling; Zhai, Xiangyu; Jin, Bin

doi:10.3389/fsurg.2022.1003948

Cited by 3 publications

(3 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As reported in a meta-analysis conducted by Guerrini et al (53), and in three more, Western and Eastern, recent experiences, laparoscopic surgery was consistently associated with better outcome compared with open surgery in terms of blood loss, transfusions, numbers of Pringle manoeuvres, hospital stay, and postoperative morbidity (54)(55)(56).…”

Section: Minimally Invasive Surgerymentioning

confidence: 88%

A narrative review of intrahepatic cholangiocarcinoma: a surgical curative option

Melandro¹,

Nasto²,

Ginesini³

et al. 2023

Chin Clin Oncol

View full text Add to dashboard Cite

Background and Objective: Cholangiocarcinoma (CCA) is the second commonest primary liver malignancy. Nowadays, the only available treatment with curative intent of intrahepatic cholangiocarcinoma (iCCA) is surgical resection, with a 5-year overall survival (OS) of 25-40%. However, recurrence rate remains high. In this comprehensive review, we describe the newest surgical strategies for iCCA management, including vascular resection, the role of mini-invasive surgery, liver transplant, strategies for future liver remnant augmentation, and the role of neoadjuvant therapies.Methods: A review of medical databases (PubMed, Scopus and Cochrane Database) was conducted selecting most relevant articles in English language without a specific timeframe.

show abstract

Section: Minimally Invasive Surgerymentioning

confidence: 88%

A narrative review of intrahepatic cholangiocarcinoma: a surgical curative option

Melandro¹,

Nasto²,

Ginesini³

et al. 2023

Chin Clin Oncol

View full text Add to dashboard Cite

show abstract

“…LLR has the advantages of light postoperative pain, fast recovery, and fewer complications [28][29][30].…”

Section: Discussionmentioning

confidence: 99%

The application of self-made liver suspension device in 3D laparoscopic non-anatomical resection of liver VI and VII segments tumors

Chen,

Jin,

Hao

et al. 2024

Preprint

View full text Add to dashboard Cite

Objective: To investigate the effect of self-made liver suspension device in 3D laparoscopic non-anatomical resection of liver VI and VII segments tumors. Methods: The clinical data of 79 patients who underwent non-anatomical resection of liver VI and VII segments tumors at the Second Hospital of Hebei Medical University from June 2016 to June 2022 were retrospectively analyzed, divided into SDLG group and CLG group. The SDLG group used the self-made liver suspension device for 3D laparoscopic resection, and the CLG group received conventional 3D laparoscopic resection; the clinical data were compared to evaluate the efficacy. Results: The operation time in SDLG group was significantly shorter than that in CLG group, the intraoperative bleeding volume and liver portal blockage time were significantly reduced, and the postoperative complications were alleviated; there was no significant difference in hospital stay, drainage tube removal time, bedside time, and postoperative flatus time. Conclusion: The self-made liver suspension device can shorten the operation time and liver portal blockage time, reduce intraoperative bleeding, alleviate postoperative complications, and improve the safety of non-anatomical resection of liver VI and VII segments tumors. It is worth further clinical promotion.

show abstract

“…Several recent studies analyzed the impacts of laparoscopic surgery on the short-term and oncological outcomes of iCCA [66][67][68][69].…”

Section: Minimally Invasive Surgerymentioning

confidence: 99%

New Insights into Surgical Management of Intrahepatic Cholangiocarcinoma in the Era of “Transplant Oncology”

Melandro,

Ghinolfi,

Gallo

et al. 2023

Gastroenterology Insights

View full text Add to dashboard Cite

Intrahepatic cholangiocarcinoma (iCCA) represents the second most frequent type of primary liver neoplasm. The diagnosis and treatment of patients with iCCA involves many challenges. To date, surgical resection with negative margins is the main curative option, achieving an acceptable long-term survival. Despite enabling a considerable improvement in the outcome, iCCA recurrence after surgery is still common. Tumor extension and the histological subtype, as well as vascular and lymph node involvements, are key factors used to define the prognosis. In this narrative review, we aimed to discuss the potential benefits of using different surgical strategies in the field of iCCA, including vascular resection, the mini-invasive approach, liver transplantation, the mechanism used to enable future liver remnant augmentation, and lymph node dissection. We also discussed the new protocols developed in the field of systemic treatment, including immunotherapy and molecular targeted therapy. Recent advancements in the diagnosis, surgical treatment, and understanding of tumor biology have changed the landscape in terms of treatment options. Creating a multidisciplinary tumor board is essential to achieving the best patient outcomes. Further investigational trials are required with the intent of tailoring the treatments and establishing the right patient population who would benefit from the use of new therapeutics algorithms.

show abstract

Laparoscopic vs. open anatomical hepatectomy for intrahepatic cholangiocarcinoma: A retrospective cohort study

Cited by 3 publications

References 27 publications

A narrative review of intrahepatic cholangiocarcinoma: a surgical curative option

A narrative review of intrahepatic cholangiocarcinoma: a surgical curative option

The application of self-made liver suspension device in 3D laparoscopic non-anatomical resection of liver VI and VII segments tumors

New Insights into Surgical Management of Intrahepatic Cholangiocarcinoma in the Era of “Transplant Oncology”

Contact Info

Product

Resources

About